When Do Efficacy Outcomes in Clinical Trials Correlate With Clinical Relevance? Analysis of Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3.75% Gel in Moderate to Severe Acne Vulgaris

被引：0

作者：

Del Rosso, James Q. ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
,11
,12
,13
]}

机构：

[1] Lakes Dermatol, Las Vegas, NV 89117 USA

[2] Del Rosso Dermatol Res Ctr, Las Vegas, NV 89117 USA

[3] Allergan Pharmaceut Inc, Irvine, CA 92612 USA

[4] Bayer Hlth Care Pharmaceut, Whippany, NJ 07981 USA

[5] Galderma Labs LP, Ft Worth, TX 76177 USA

[6] Sun Pharmaceut Ind Ltd, Bombay, Maharashtra, India

[7] Valeant Pharmaceut North Amer LLC, Durham, NC 27701 USA

[8] Aqua Pharmaceut, Exton, PA 19341 USA

[9] BioPharmX Inc, Menlo Pk, CA 94025 USA

[10] Cutanea Life Sci, Wayne, PA USA

[11] Dermira, Menlo Pk, CA USA

[12] Foamix Pharmaceut, Rehovot, Israel

[13] Johnson & Johnson Serv Inc, New Brunswick, NJ 08933 USA

来源：

CUTIS | 2016年 / 98卷 / 01期

关键词：

ADHERENCE; THERAPY; TOLERABILITY; GENDER; IMPACT;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：21 / 25

页数：5

共 50 条

[1] Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations
Gold, Linda Stein
JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (09) : 969 - 974
[2] Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris
Nguyen, Tuyet A.
Eichenfield, Lawrence F.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2015, 8 : 549 - 554
[3] An Aqueous Gel Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% for the Once-Daily Treatment of Moderate to Severe Acne Vulgaris
Pariser, David M.
Rich, Phoebe
Cook-Bolden, Fran E.
Korotzer, Andrew
JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (09) : 1083 - 1089
[4] Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel
Amar, Laetitia
Kircik, Leon H.
JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (10) : 1107 - 1112
[5] Fitzpatrick Skin Types and Clindamycin Phosphate 1.2%/Benzoyl Peroxide Gel: Efficacy and Tolerability of Treatment in Moderate to Severe Acne
Callender, Valerie D.
JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (05) : 643 - 648
[6] Treatment of Moderate to Severe Acne Vulgaris in a Hispanic Population: A Post-Hoc Analysis of Efficacy and Tolerability of Clindamycin Phosphate 1.2%/Benzoyl Peroxide 2.5% Gel
Cook-Bolden, Fran E.
JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (04) : 455 - 459
[7] Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris
Kircik, Leon H.
JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (06) : 543 - 546
[8] Efficacy of a fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate to severe acne Diane
Thiboutot, Diane
Shalita, Alan
Zaenglein, Andrea
Calvarese, Barry
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB22 - AB22
[9] Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Low Concentration Benzoyl Peroxide (2.5%) Aqueous Gel in Moderate or Severe Acne Subpopulations
Webster, Guy
Rich, Phoebe
Gold, Michael H.
Mraz, Serena
Calvarese, Barry
Chen, Diana
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 736 - 743
[10] Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey
Baldwin, Hilary
Harper, Julie C.
Zeichner, Joshua A.
Draelos, Zoe D.
Eichenfield, Lawrence E.
Gold, Michael
Gold, Linda Stein
Kircik, Leon
JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (11) : 1017 - 1024

← 1 2 3 4 5 →